Skip to main content
. 2022 Dec;11(6):848–860. doi: 10.21037/hbsn-21-419

Table 4. Median survival, complication rates, operation time and blood loss of liver resection for HCC with MVI.

Outcomes and complications Number of studies Number of patients Refer to sub-header
Median survival (months)
   Overall 21 3,909 14.39 (10.99–18.84)
    PVTT only 13 2,437 12.97 (10.48–16.06)
    PVTT and/or HVTT 8 1,472 16.83 (10.12–27.98)
All complications (%)
   Overall 13 1,698 30.52 (23.60–38.44)
    PVTT only 8 1,039 27.37 (19.72–36.63)
    PVTT and/or HVTT 5 659 36.59 (24.44–50.72)
Minor complications (%)
   Overall 9 669 24.87 (20.09–30.36)
    PVTT only 6 474 21.44 (17.15–26.45)*
    PVTT and/or HVTT 3 195 31.79 (25.64–38.66)*
Major complications (%)
   Overall 16 1,687 6.17 (3.53–10.56)
    PVTT only 12 1,327 4.86 (2.10–10.82)
    PVTT and/or HVTT 4 360 9.17 (6.59–12.61)*
Operation time (min)
   Overall 9 1,253 219.42 (182.77–256.07)
    PVTT only 5 749 185.89 (181.06–190.73)
    PVTT and/or HVTT 4 504 146.96 (137.32–156.60)
Blood loss (mL)
   Overall 8 1,290 655.76 (434.94–876.58)
    PVTT only 6 824 618.28 (342.81–893.75)

*, all I2>57.4 with P value <0.05, except for values marked. HCC, hepatocellular carcinoma; MVI, macrovascular invasion; PVTT, portal vein tumor thrombosis; HVTT, hepatic vein tumor thrombosis.